Placebo Controlled Dose-Response Study Of PD-217,014 In The Treatment Of Postherpetic Neuralgia

A 13-Week, Randomized, Double-Blind, Multicenter, Placebo-Controlled Study Of Pregabalin For Postherpetic Neuralgia

NCT00394901 ·Status: COMPLETED ·Phase: PHASE3

Safety and Efficacy of Gabapentin in Postherpetic Neuralgia

NCT00636636 ·Status: COMPLETED ·Phase: PHASE3

Safety and Efficacy of Gabapentin in Postherpetic Neuralgia

NCT00335933 ·Status: COMPLETED ·Phase: PHASE3

Study to Find Out if Therapy With the Drug Pregabalin Relieves Pain During Shingles Compared With Placebo

NCT00352651 ·Status: TERMINATED ·Phase: PHASE2

Oral Gabapentin in Management of Chronic Pelvic Pain in Females: A Randomised Placebo-controlled Study.

NCT02918760 ·Status: UNKNOWN ·Phase: PHASE3

A Clinical Study in Subjects With Neuropathic Pain From PHN Who Have Had an Inadequate Response to Gabapentin Treatment

NCT00617461 ·Status: COMPLETED ·Phase: PHASE2

A Study In Patients With Neuropathic Pain From Post-Herpetic Neuralgia (PHN)

NCT00619476 ·Status: COMPLETED ·Phase: PHASE2

Assessment of the Analgesic Effects of PF-06372865 in Healthy Volunteers Using Evoked Pain Endpoints

NCT02238717 ·Status: COMPLETED ·Phase: PHASE1

Efficacy and Safety of CNV2197944 Versus Placebo in Patients With Post-herpetic Neuralgia

NCT01848730 ·Status: COMPLETED ·Phase: PHASE2

Pilot Study Of Pregabalin And Prediction Of Treatment Response In Patients With Postherpetic Neuralgia

NCT01603394 ·Status: TERMINATED ·Phase: PHASE4

Neuropathic Pain Syndrome Patient Study (MK-0000-072)

NCT00570310 ·Status: COMPLETED ·Phase: PHASE1

A Study Of The Efficacy Of Gabapentin In Neuropathic Pain Patients As Measured By Quantitative Sensory Testing

NCT00674687 ·Status: COMPLETED ·Phase: NA

Eslicarbazepine Acetate as Therapy in Post-Herpetic Neuralgia

NCT01124097 ·Status: TERMINATED ·Phase: PHASE3

Analgesic Efficacy and Safety of V116517 in Subjects With Moderate to Severe Chronic Pain Due to Postherpetic Neuralgia (PHN)

NCT01688947 ·Status: COMPLETED ·Phase: PHASE2

Pregabalin vs Placebo in Treatment of Neuropathic Pain Associated With Diabetic Peripheral Neuropathy

NCT00143156 ·Status: COMPLETED ·Phase: PHASE3

Safety and Efficacy of Gabapentin for Neuropathic Pain in Fabry Disease

NCT01588314 ·Status: WITHDRAWN ·Phase: PHASE2

Efficacy and Safety of Gabapentin/B-complex Versus Pregabalin in Diabetic Peripheral Neuropathy Pain Management

NCT01364298 ·Status: COMPLETED ·Phase: PHASE4

Gabapentin in Treating Peripheral Neuropathy in Cancer Patients Undergoing Chemotherapy

NCT00027963 ·Status: COMPLETED ·Phase: PHASE3

Efficacy of Pregabalin for the Treatment of Acute Herpetic Neuralgia

NCT03809702 ·Status: COMPLETED ·Phase: PHASE4

[S,S]-Reboxetine Add-On Trial

NCT00334685 ·Status: TERMINATED ·Phase: PHASE2

Randomized, Double-Blind, Multicenter, Placebo-Controlled Study Of Pregabalin For Pain Associated With Diabetic Peripheral Neuropathy

NCT00553475 ·Status: COMPLETED ·Phase: PHASE3

A Study to Assess the Safety and Efficacy of 7 Days Treatment With a Novel Analgesic in Subjects With Peripheral Neuropathic Pain

NCT01485094 ·Status: TERMINATED ·Phase: PHASE2

Study to Determine if a Reduction in Pain Can be Measured in Spinal Cord Injured Patients Using a New Study Design

NCT00978341 ·Status: TERMINATED ·Phase: NA

Pregabalin Versus Placebo In The Treatment Of Neuropathic Pain Associated With HIV Neuropathy

NCT01049217 ·Status: TERMINATED ·Phase: PHASE3

A Safety and Efficacy Study of AGN-214868 in Patients With Postherpetic Neuralgia

NCT01678924 ·Status: TERMINATED ·Phase: PHASE2